Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

35.220
-1.320-3.61%
Volume:448.60K
Turnover:15.62M
Market Cap:8.70B
PE:274.04
High:35.500
Open:34.520
Low:34.400
Close:36.540
52wk High:53.450
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.80
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.129
ROE:0.82%
ROA:-0.80%
PB:1.50
PE(LYR):274.04
PS:6.03

Loading ...

Movement Alert|CANSINOBIO Rises 5.12% in Regular Trading, Biotech Sector Strengthens Ahead of Upcoming Earnings Briefing

Market Focus
·
Sep 14

Movement Alert|CANSINOBIO Falls 5.51% in Regular Trading, Trading at HK$25.38

Market Focus
·
Sep 11

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
Sep 10

Movement Alert|CANSINOBIO Falls 5.09% in Regular Trading, Biotech Sector Broadly Weak as Post-Rally Profit-Taking Intensifies

Market Focus
·
Sep 10

Movement Alert|CANSINOBIO Rises 5.47% in Regular Trading, Strong H1 Results and mRNA Tumor Vaccine Catalyst Drive Gains

Market Focus
·
Sep 08

AH Premium Rankings Update: September 3 Market Close

Stock News
·
Sep 03

CanSino Biologics' Global Revenue Soars 4,724% in First Half, Systemic Expansion Strategy Unlocks Growth Potential

Deep News
·
Sep 02

AH Premium Rankings for September 2nd Market Close

Stock News
·
Sep 02

Movement Alert|CANSINOBIO Rises 7.93% in Regular Trading, CLSA Maintains Outperform Rating with 56% Upside Potential

Market Focus
·
Sep 02

AH Share Premium Rankings for September 1st

Stock News
·
Sep 01

CanSino Biologics Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.
·
Sep 01

AH Share Premium Report: August 31 Market Close

Stock News
·
Aug 31

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Reuters
·
Aug 31

Movement Alert|CANSINOBIO Falls 5.48% in Regular Trading, Profit-Taking Continues After Multiple Catalysts Drove Sharp Rally

Market Focus
·
Aug 31

AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium

Stock News
·
Aug 28

Movement Alert|CANSINOBIO Falls 5.4% in Regular Trading, Profit-Taking Continues After Multi-Catalyst Rally and H1 Results Release

Market Focus
·
Aug 28

CanSinoBIO Posts 46% Revenue Growth and Near-Break-Even First-Half Result, Boosted by Meningococcal and Pneumococcal Vaccines

Bulletin Express
·
Aug 27

AH Premium Rankings for August 27: A Market Overview

Stock News
·
Aug 27

Movement Alert|CANSINOBIO Declines 5.04% in Regular Trading, Pullback Continues After mRNA Cooperation-Fueled Surge

Market Focus
·
Aug 27

CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines

MT Newswires Live
·
Aug 26